References analysis of the Wikipedia article "Daptomycin" in the English version

doi.org

Baltz RH (April 2009). "Daptomycin: mechanisms of action and resistance, and biosynthetic engineering". Current Opinion in Chemical Biology. 13 (2): 144–151. doi:10.1016/j.cbpa.2009.02.031. PMID 19303806.

Henken S, Bohling J, Martens-Lobenhoffer J, Paton JC, Ogunniyi AD, Briles DE, et al. (February 2010). "Efficacy profiles of daptomycin for treatment of invasive and noninvasive pulmonary infections with Streptococcus pneumoniae". Antimicrobial Agents and Chemotherapy. 54 (2): 707–717. doi:10.1128/AAC.00943-09. PMC 2812129. PMID 19917756.

Mo Y, Nehring F, Jung AH, Housman ST (June 2016). "Possible Hepatotoxicity Associated With Daptomycin: A Case Report and Literature Review". Journal of Pharmacy Practice. 29 (3): 253–256. doi:10.1177/0897190015625403. PMID 26763341. S2CID 26176155.

Kazory A, Dibadj K, Weiner ID (March 2006). "Rhabdomyolysis and acute renal failure in a patient treated with daptomycin". The Journal of Antimicrobial Chemotherapy. 57 (3): 578–579. doi:10.1093/jac/dki476. PMID 16410267.

Odero RO, Cleveland KO, Gelfand MS (June 2009). "Rhabdomyolysis and acute renal failure associated with the co-administration of daptomycin and an HMG-CoA reductase inhibitor". The Journal of Antimicrobial Chemotherapy. 63 (6): 1299–1300. doi:10.1093/jac/dkp127. PMID 19346518.

Pogliano J, Pogliano N, Silverman JA (September 2012). "Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins". Journal of Bacteriology. 194 (17): 4494–4504. doi:10.1128/JB.00011-12. PMC 3415520. PMID 22661688.

Kirkham S, Castelletto V, Hamley IW, Inoue K, Rambo R, Reza M, Ruokolainen J (July 2016). "Self-Assembly of the Cyclic Lipopeptide Daptomycin: Spherical Micelle Formation Does Not Depend on the Presence of Calcium Chloride" (PDF). ChemPhysChem. 17 (14): 2118–2122. doi:10.1002/cphc.201600308. PMID 27043447. S2CID 44681934.

Shoemaker DM, Simou J, Roland WE (June 2006). "A review of daptomycin for injection (Cubicin) in the treatment of complicated skin and skin structure infections". Therapeutics and Clinical Risk Management. 2 (2): 169–174. doi:10.2147/tcrm.2006.2.2.169. PMC 1661656. PMID 18360590.

Feng J, Weitner M, Shi W, Zhang S, Zhang Y (2016). "Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime". Frontiers in Microbiology. 7: 62. doi:10.3389/fmicb.2016.00062. PMC 4748043. PMID 26903956.

Cleveland KO, Gelfand MS (May 2013). "Daptomycin-Nonsusceptible Enterococcal Infections". Infectious Diseases in Clinical Practice. 21 (3): 213. doi:10.1097/IPC.0b013e31828875fc.

Pawlowski AC, Wang W, Koteva K, Barton HA, McArthur AG, Wright GD (December 2016). "A diverse intrinsic antibiotic resistome from a cave bacterium". Nature Communications. 7 13803. Bibcode:2016NatCo...713803P. doi:10.1038/ncomms13803. PMC 5155152. PMID 27929110.

Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. (November 2015). "2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)". European Heart Journal. 36 (44): 3075–3128. doi:10.1093/eurheartj/ehv319. PMID 26320109.

Antonello RM, Canetti D, Riccardi N (December 2022). "Daptomycin synergistic properties from in vitro and in vivo studies: a systematic review". The Journal of Antimicrobial Chemotherapy. 78 (1): 52–77. doi:10.1093/jac/dkac346. PMID 36227704.

Fowler VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, et al. (August 2006). "Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus". The New England Journal of Medicine. 355 (7): 653–665. doi:10.1056/NEJMoa053783. PMID 16914701.

Davis SL, McKinnon PS, Hall LM, Delgado G, Rose W, Wilson RF, Rybak MJ (December 2007). "Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes". Pharmacotherapy. 27 (12): 1611–1618. doi:10.1592/phco.27.12.1611. PMID 18041881. S2CID 30964162.

Nguyen KT, Kau D, Gu JQ, Brian P, Wrigley SK, Baltz RH, Miao V (September 2006). "A glutamic acid 3-methyltransferase encoded by an accessory gene locus important for daptomycin biosynthesis in Streptomyces roseosporus". Molecular Microbiology. 61 (5): 1294–1307. doi:10.1111/j.1365-2958.2006.05305.x. PMID 16879412. S2CID 19766889.

Miao V, Coëffet-LeGal MF, Brian P, Brost R, Penn J, Whiting A, et al. (May 2005). "Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry". Microbiology. 151 (Pt 5): 1507–1523. doi:10.1099/mic.0.27757-0. PMID 15870461.

Steenbergen JN, Alder J, Thorne GM, Tally FP (March 2005). "Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections". The Journal of Antimicrobial Chemotherapy. 55 (3): 283–288. doi:10.1093/jac/dkh546. PMID 15705644.

Mchenney MA, Hosted TJ, Dehoff BS, Rosteck PR, Baltz RH (January 1998). "Molecular cloning and physical mapping of the daptomycin gene cluster from Streptomyces roseosporus". Journal of Bacteriology. 180 (1): 143–151. doi:10.1128/JB.180.1.143-151.1998. PMC 106860. PMID 9422604.

Fischbach MA, Walsh CT (August 2006). "Assembly-line enzymology for polyketide and nonribosomal Peptide antibiotics: logic, machinery, and mechanisms". Chemical Reviews. 106 (8): 3468–3496. doi:10.1021/cr0503097. PMID 16895337.

Baltz RH (February 1998). "Genetic manipulation of antibiotic-producing Streptomyces". Trends in Microbiology. 6 (2): 76–83. doi:10.1016/S0966-842X(97)01161-X. PMID 9507643.

Baltz RH, Miao V, Wrigley SK (December 2005). "Natural products to drugs: daptomycin and related lipopeptide antibiotics". Natural Product Reports. 22 (6): 717–741. doi:10.1039/b416648p. PMID 16311632.

Baltz RH, Brian P, Miao V, Wrigley SK (February 2006). "Combinatorial biosynthesis of lipopeptide antibiotics in Streptomyces roseosporus". Journal of Industrial Microbiology & Biotechnology. 33 (2): 66–74. doi:10.1007/s10295-005-0030-y. PMID 16193281. S2CID 10856890.

Nguyen KT, Ritz D, Gu JQ, Alexander D, Chu M, Miao V, et al. (November 2006). "Combinatorial biosynthesis of novel antibiotics related to daptomycin". Proceedings of the National Academy of Sciences of the United States of America. 103 (46): 17462–17467. Bibcode:2006PNAS..10317462N. doi:10.1073/pnas.0608589103. PMC 1859951. PMID 17090667.

Kopp F, Grünewald J, Mahlert C, Marahiel MA (September 2006). "Chemoenzymatic design of acidic lipopeptide hybrids: new insights into the structure-activity relationship of daptomycin and A54145". Biochemistry. 45 (35): 10474–10481. doi:10.1021/bi0609422. PMID 16939199.

Miao V, Coëffet-Le Gal MF, Nguyen K, Brian P, Penn J, Whiting A, et al. (March 2006). "Genetic engineering in Streptomyces roseosporus to produce hybrid lipopeptide antibiotics". Chemistry & Biology. 13 (3): 269–276. doi:10.1016/j.chembiol.2005.12.012. PMID 16638532.

Baltz RH (December 2006). "Molecular engineering approaches to peptide, polyketide and other antibiotics". Nature Biotechnology. 24 (12): 1533–1540. doi:10.1038/nbt1265. PMID 17160059. S2CID 30003086.

Eisenstein BI, Oleson FB, Baltz RH (January 2010). "Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD". Clinical Infectious Diseases. 50 (Supplement_1) (published 1 February 2010): S10 – S15. doi:10.1086/647938. PMID 20067387.

Tally FP, DeBruin MF (October 2000). "Development of daptomycin for gram-positive infections". The Journal of Antimicrobial Chemotherapy. 46 (4): 523–526. doi:10.1093/jac/46.4.523. PMID 11020247.

Charles PG, Grayson ML (November 2004). "The dearth of new antibiotic development: why we should be worried and what we can do about it". The Medical Journal of Australia. 181 (10): 549–553. doi:10.5694/j.1326-5377.2004.tb06444.x. PMID 15540967. S2CID 18526863.

drugs.com

"Daptomycin Use During Pregnancy". Drugs.com. 3 December 2019. Retrieved 28 August 2020.

handle.net

hdl.handle.net

World Health Organization (2019). Executive summary: the selection and use of essential medicines 2019: report of the 22nd WHO Expert Committee on the selection and use of essential medicines. Geneva: World Health Organization. hdl:10665/325773. WHO/MVP/EMP/IAU/2019.05. License: CC BY-NC-SA 3.0 IGO.

World Health Organization (2019). The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2019 (including the 21st WHO Model List of Essential Medicines and the 7th WHO Model List of Essential Medicines for Children). Geneva: World Health Organization. hdl:10665/330668. ISBN 9789241210300. ISSN 0512-3054. WHO technical report series;1021.

World Health Organization (2019). Critically important antimicrobials for human medicine (6th revision ed.). Geneva: World Health Organization. hdl:10665/312266. ISBN 9789241515528.

nih.gov

pubmed.ncbi.nlm.nih.gov

Baltz RH (February 1998). "Genetic manipulation of antibiotic-producing Streptomyces". Trends in Microbiology. 6 (2): 76–83. doi:10.1016/S0966-842X(97)01161-X. PMID 9507643.

Tally FP, DeBruin MF (October 2000). "Development of daptomycin for gram-positive infections". The Journal of Antimicrobial Chemotherapy. 46 (4): 523–526. doi:10.1093/jac/46.4.523. PMID 11020247.

ncbi.nlm.nih.gov

dailymed.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

worldcat.org

search.worldcat.org

Daptomycin (English Wikipedia)

cubicin.com

doi.org

drugs.com

europa.eu

ema.europa.eu

handle.net

hdl.handle.net

harvard.edu

ui.adsabs.harvard.edu

medicines.org.uk

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

dailymed.nlm.nih.gov

reading.ac.uk

centaur.reading.ac.uk

semanticscholar.org

api.semanticscholar.org

tga.gov.au

web.archive.org

worldcat.org

search.worldcat.org